Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The China-Uzbekistan Medicine Technical Park is a strategic pharmaceutical and biotechnological hub established through a partnership between the Chinese Academy of Sciences and the Ministry of Innovative Development of Uzbekistan. Located in Tashkent, the park focuses on the research, development, and industrial production of modern medicines, traditional herbal remedies, and vaccines. It gained international prominence for its role in the co-development and large-scale production of the ZF-UZ-VAC2001 COVID-19 vaccine. The facility integrates high-tech laboratories with GMP-certified manufacturing lines to serve the Central Asian market. Its operations bridge Chinese pharmaceutical technology with Uzbekistan's rich botanical resources to create a regional center for drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China-Uzbekistan Medicine Technical Park.